Effect of Antenatal Magnesium Sulfate Exposure on Patent Ductus Arteriosus in Premature Infants
Auswirkung einer pränatalen Magnesiumsulfat-Exposition auf den persistierenden Ductus arteriosus bei Frühgeborenen
American Journal of Perinatology · 01.09.2024 · 41 (12) · 1665-1672
DOI: 10.1055/s-0044-1779620 ↗Auf einen Blick
In einer retrospektiven Studie mit 300 Frühgeborenen war hsPDA nach pränataler MgSO4-Exposition insgesamt nicht häufiger. Eine kumulative Dosis >20 g war jedoch mit einem höheren hsPDA-Risiko assoziiert.
Fragestellung
Besteht bei Frühgeborenen ein Zusammenhang zwischen pränataler MgSO4-Exposition und PDA bzw. hsPDA?
Methode
Retrospektive Studie bei Frühgeborenen zwischen 240/7 und 316/7 Schwangerschaftswochen; Auswertung klinischer und echokardiografischer Daten sowie mütterlicher MgSO4-Exposition und Dosen.
Ergebnisse
300 Säuglinge, 98 (32,6 %) mit antenatalem MgSO4. hsPDA: adjustiertes OR 1,6 (95 %-KI 0,849–3,118; p=0,146). Bei >20 g: adjustiertes OR 3,829 (95 %-KI 1,068–13,728; p=0,039).
Schlussfolgerung der Autor:innen
Antenatale MgSO4-Exposition kann die Inzidenz von hsPDA erhöhen, beeinflusst aber möglicherweise nicht die Raten von PDA-Ligatur oder offenem PDA bei Entlassung.
Kernaussagen
- hsPDA insgesamt nicht signifikant häufiger unter MgSO4
- >20 g MgSO4 mit höherem hsPDA-Risiko assoziiert
- PDA-Ligatur und offener PDA bei Entlassung ähnlich
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.09.2024. Verfasst von Emel Okulu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Ductus Arteriosus, Patent, Magnesium Sulfate, Gestational Age, Infant, Premature. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Neonatologie
Abstract (Originalsprache)
Objective
Magnesium sulfate (MgSO4) provides effective fetal neuroprotection. However, there is conflicting evidence regarding the association between antenatal MgSO4 exposure and patent ductus arteriosus (PDA). Thus, herein, we aimed to evaluate the association between antenatal MgSO4 exposure and PDA. Study Design Preterm infants born between 240/7 and 316/7 weeks of gestation were included in this retrospective study. Infants who died within the first 72 hours of life and those with significant congenital anomalies were excluded from the study. Echocardiographic and clinical assessment parameters were used to define PDA and hemodynamically significant PDA (hsPDA). Treatments were planned according to the standard protocols of the unit. The following data were collected from hospital medical records: perinatal characteristics, neonatal outcomes, detailed PDA follow-up findings, and maternal characteristics including MgSO4 exposure and doses.
Results
Of the 300 included infants, 98 (32.6%) were exposed to antenatal MgSO4. hsPDA rates were similar in the infants exposed and not exposed to antenatal MgSO4, when adjusted for antenatal steroid administration, gestational age, and birth weight (OR: 1.6, 95% CI: 0.849–3.118, p = 0.146). The rates of PDA ligation and open PDA at discharge were similar between the groups. A cumulative MgSO4 dose of >20 g was associated with an increased risk of hsPDA (crude OR: 2.476, 95% CI: 0.893–6.864, p = 0.076; adjusted OR: 3.829, 95% CI: 1.068–13.728, p = 0.039). However, the cumulative dose had no effect on the rates of PDA ligation or open PDA at discharge. Rates of prematurity-related morbidities and mortality were similar between the groups.
Conclusion
Although antenatal MgSO4 exposure may increase the incidence of hsPDA, it may not affect the rates of PDA ligation or open PDA at discharge. Further studies are required to better evaluate the dose-dependent outcomes and identify the MgSO4 dose that not only provides neuroprotection but also has the lowest risk of adverse effects. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye.
- Division of Perinatology, Department of Obstetrics and Gynecology, Ankara University Faculty of Medicine, Ankara, Türkiye.
- Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye.
- Department of Obstetrics and Gynecology, Ankara University Faculty of Medicine, Ankara, Türkiye.
- Division of Pediatric Cardiology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye.
ORCID-Profile: Emel Okulu, Elvis Kraja, Yasemin Ezgi Kostekci, Erdal Seker
Zitieren
APA
Okulu, E., Kraja, E., Kostekci, Y. E., Seker, E., Ozisik, M. S., Sarısoy, D., Aslan, B., Çakır, M. S., Demirtaş, F., Ramoğlu, M. G., Uçar, T., Erdeve, O., Atasay, B., Koc, A., & Arsan, S. (2024). Effect of Antenatal Magnesium Sulfate Exposure on Patent Ductus Arteriosus in Premature Infants. American Journal of Perinatology, 41(12), 1665-1672. https://doi.org/10.1055/s-0044-1779620
Vancouver
Okulu E, Kraja E, Kostekci YE, Seker E, Ozisik MS, Sarısoy D, et al. Effect of Antenatal Magnesium Sulfate Exposure on Patent Ductus Arteriosus in Premature Infants. American Journal of Perinatology. 2024;41(12):1665-1672. doi:10.1055/s-0044-1779620
BibTeX
@article{Okulu2024,
author = {Okulu, Emel and Kraja, Elvis and Kostekci, Yasemin Ezgi and Seker, Erdal and Ozisik, Mehmet Seckin and Sarısoy, Doğacan and Aslan, Batuhan and Çakır, Maide Selin and Demirtaş, Ferhan and Ramoğlu, Mehmet Gökhan and Uçar, Tayfun and Erdeve, Omer and Atasay, Begum and Koc, Acar and Arsan, Saadet},
title = {Effect of Antenatal Magnesium Sulfate Exposure on Patent Ductus Arteriosus in Premature Infants},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {12},
pages = {1665--1672},
doi = {10.1055/s-0044-1779620}
}
EUVIMED